The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
- 28 August 2003
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (5) , 914-922
- https://doi.org/10.1016/s0735-1097(03)00856-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardiumBritish Journal of Pharmacology, 2001
- Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardiumBritish Journal of Pharmacology, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockersBlood Pressure, 1999
- The role of third-generation beta-blocking agents in chronic heart failureClinical Cardiology, 1998
- Increased Insulin and Glucose Levels in Heart Failure (HF)Journal of the American College of Cardiology, 1998
- Alterations in myocardial contractile proteins in diabetes mellitusCoronary Artery Disease, 1996
- Abnormal mechanical function in diabetesCoronary Artery Disease, 1996
- Diabetic cardiomyopathyAmerican Heart Journal, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987